Artivion | CRY - 营业费用

股票价格

35.29

每天变化

-1.10 -3.02%

每月一次

-8.46%

每年

45.53%

Q1 预测

35.04

金融业

USD

USD 884.8M

现金及等价物

USD 64.91M

USD 42.85M

USD 358.08M

USD 101.56M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 448.23M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 217.81M

USD 1.46B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 92.43M

贸易债权人

USD 16.04M

应收帐款人

USD 103.68M

	营业费用	更改		日
Abbott	USD 9.21B		17M	2025-12
Accuray	USD 37.18M		567K	2024-12
AngioDynamics	USD 81.95M		1.68M	2025-09
Artivion	USD 111.2M		9.45M	2025-12
AtriCure	USD 138.01M		3.95M	2025-12
Baxter International	USD 3.19B		554.4M	2025-12
Becton, Dickinson and Co.	USD 4.59B		476M	2025-12
Boston Scientific	USD 4.04B		18M	2025-12
Edwards Lifesciences	USD 1.2B		71.3M	2025-12
Inogen	USD 49.14M		665K	2024-09
Integra LifeSciences	USD 368.92M		668.65M	2025-12
J&J	USD 18.97B		2.38B	2025-12
Mesa Laboratories	USD 33.98M		2.03M	2024-12
Orthofix International	USD 213.79M		12.36M	2025-12
Pfizer	USD 12.91B		79.89B	2025-12
ResMed	USD 925.21M		51.98M	2025-12
Stryker	USD 5.2B		505M	2025-12
Surmodics	USD -245.35M		363.49M	2024-09
Tandem Diabetes Care	USD 282.09M		9.97M	2025-12
Teleflex	USD 532.64M		3.29B	2025-12
Terumo	JPY 252.74B		22.88B	2025-12
Trinity Biotech	USD 14.82M		7.81M	2025-09